secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solana Co (HSDT)
CIK:        0001610853
Form:       8-K
Filed at:   2023-03-09T23:59:59+00:00
Accession:  0001558370-23-003320
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Helius Medical Q4 revenue $282K, FY22 rev $787K (+51% YoY); net loss narrows
----------------------------------------------------------------------------

- Q4 revenue $282K (+9% YoY, +44% sequential); FY22 revenue $787K (+51% YoY).
- Net loss Q4 $4.9M ($0.17/sh) vs $4.1M ($1.31/sh) in Q4 2021; FY22 net loss $14.1M ($1.04/sh).
- Cash $14.5M at Dec 31, 2022, no debt; Q4 cash burn $2.1M vs prior quarterly avg $4.1M.
- Expects 2023 revenue to exceed 2022 and increase during year; reimbursement needed for full potential.
- Health Canada authorized PoNS for gait deficit due to mild/moderate stroke; launched UpScript e-commerce site.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610853/000155837023003320/0001558370-23-003320-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610853/000155837023003320/hsdt-20230309x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-003320

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer